Free Email Alerts

GLP-1 Price Drop and Shortage Alerts

We track 90 online GLP-1 programs and the FDA shortage database. When a price drops or a shortage status changes, you get a short email with the diff. That's it.

Price drop alerts

Pick this if you're price-shopping. We send an email when:

Any provider in our index drops their monthly price by 10% or more
A new lower-priced compounded program enters the index
A manufacturer (Lilly Direct, NovoCare) cuts cash-pay pricing

Shortage alerts

Pick this if you're worried about supply. We send an email when:

An FDA shortage status changes (resolved or re-listed)
A specific dose strength comes back in stock or goes out
A major compounding pathway opens or closes

Both at once

Most readers want both. Sign up here for both lists.

Why we built this

GLP-1 prices change weekly. Manufacturers run promos. Compounded providers undercut each other. The FDA updates the shortage list quietly. Most readers don't have time to monitor 90 provider pages and an FDA database.

So we do it. We track everything in our pricing index and our shortage tracker. When something material changes, you get a short email. Nothing else.

Sample alert

Subject: Mochi Health dropped compounded sema to $129/mo (was $178)
Body:
Mochi Health cut their compounded semaglutide program from $178/mo to $129/mo as of April 24, 2026. That's a 27% drop. New median across our index is now $189/mo (was $199).
Full pricing index: clearmetabolic.com/research/glp1-cash-pay-pricing-index

Privacy

Email goes to Buttondown (our newsletter platform). We don't sell or share. One-click unsubscribe in every email. Read our editorial policy.